LLY vs NVS: Fair Value Comparison

Eli Lilly and Company vs. Novartis AG ADR · General Drug Manufacturers

LLY's model fair value sits 46.1% below its current price; NVS's model fair value sits 5.3% above its current price. Of the two, NVS trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-10-22.

LLYNVS
Price$1307.21$154.51
Model fair value (multi-method blend)$704.33$162.77
Model fair value differential-46.1%+5.3%
Methods with a model value above price10 of 106 of 9
Fundamental strengthA-B+
Next earnings report2026-10-292026-10-27

Differential = model fair value versus the current price; positive means the price sits below the model estimate.

More comparisons

LLY vs JNJ · LLY vs ABBV · LLY vs MRK · LLY vs AZN · JNJ vs NVS · ABBV vs NVS · MRK vs NVS · NVS vs AZN · All General Drug Manufacturers stocks · Compare any two stocks